Analyzing Johnson & Johnson's Steady Growth, Dividend, and Analyst Outlook episode artwork

EPISODE · Mar 18, 2025 · 2 MIN

Analyzing Johnson & Johnson's Steady Growth, Dividend, and Analyst Outlook

from Johnson & Johnson News Daily · host Inception Point AI

As of the latest update, Johnson and Johnson's stock price is around one hundred sixty-two dollars and twelve cents per share. The trading volume has been notably lower than average, with recent days seeing a significant decline compared to the usual daily volume. For instance, on a recent trading day, the volume was eighty-two percent below the average daily volume of approximately seven million, three hundred thirty-two thousand shares. Recently, Johnson and Johnson reported strong fourth-quarter results for two thousand twenty-four, with a five-point-three percent increase in sales. The company's MedTech segment showed significant growth, driven by electrophysiology products and wound closure solutions. For the full year two thousand twenty-five, Johnson and Johnson expects operational sales to grow between two-point-five and three-point-five percent. In terms of analyst updates, several firms have adjusted their price targets for Johnson and Johnson. Bank of America raised its target from one hundred fifty-nine dollars to one hundred seventy-one dollars, while Royal Bank of Canada maintained an outperform rating with a target of one hundred eighty-one dollars. Citigroup reduced its target from one hundred eighty-five dollars to one hundred seventy-five dollars but maintained a buy rating. Overall, the consensus among analysts is a moderate buy with a target price of approximately one hundred seventy-one dollars and thirty-three cents. Johnson and Johnson also recently announced a quarterly dividend of one dollar and twenty-four cents per share, reflecting a yield of approximately three-point-zero-four percent. The company's financial health and consistent dividend payouts make it an attractive option for investors seeking stability. Despite the recent low trading volume, Johnson and Johnson remains a significant player in the healthcare sector, with a market capitalization of nearly three hundred ninety-four billion dollars. For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX This content was created in partnership and with the help of Artificial Intelligence AI.

As of the latest update, Johnson and Johnson's stock price is around one hundred sixty-two dollars and twelve cents per share. The trading volume has been notably lower than average, with recent days seeing a significant decline compared to the usual daily volume. For instance, on a recent trading day, the volume was eighty-two percent below the average daily volume of approximately seven million, three hundred thirty-two thousand shares. Recently, Johnson and Johnson reported strong fourth-quarter results for two thousand twenty-four, with a five-point-three percent increase in sales. The company's MedTech segment showed significant growth, driven by electrophysiology products and wound closure solutions. For the full year two thousand twenty-five, Johnson and Johnson expects operational sales to grow between two-point-five and three-point-five percent. In terms of analyst updates, several firms have adjusted their price targets for Johnson and Johnson. Bank of America raised its target from one hundred fifty-nine dollars to one hundred seventy-one dollars, while Royal Bank of Canada maintained an outperform rating with a target of one hundred eighty-one dollars. Citigroup reduced its target from one hundred eighty-five dollars to one hundred seventy-five dollars but maintained a buy rating. Overall, the consensus among analysts is a moderate buy with a target price of approximately one hundred seventy-one dollars and thirty-three cents. Johnson and Johnson also recently announced a quarterly dividend of one dollar and twenty-four cents per share, reflecting a yield of approximately three-point-zero-four percent. The company's financial health and consistent dividend payouts make it an attractive option for investors seeking stability. Despite the recent low trading volume, Johnson and Johnson remains a significant player in the healthcare sector, with a market capitalization of nearly three hundred ninety-four billion dollars. For more http://www.quietplease.ai Stock up on these deals https://amzn.to/3QFpYIX This content was created in partnership and with the help of Artificial Intelligence AI.

NOW PLAYING

Analyzing Johnson & Johnson's Steady Growth, Dividend, and Analyst Outlook

0:00 2:11

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of Johnson & Johnson News Daily?

This episode is 2 minutes long.

When was this Johnson & Johnson News Daily episode published?

This episode was published on March 18, 2025.

What is this episode about?

As of the latest update, Johnson and Johnson's stock price is around one hundred sixty-two dollars and twelve cents per share. The trading volume has been notably lower than average, with recent days seeing a significant decline compared to the...

Can I download this Johnson & Johnson News Daily episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!